- Description
- Table of Contents
- Request Sample
The Global Nephropathic Cystinosis Treatment Market is expected to reach $309.23 million by 2027 growing at a CAGR of 4.9% from 2020 to 2027. Nephropathic cystinosis is a rare form of the disease. Nephropathic cystinosis treatment comprises cysteamine depletion therapy with indicative treatment for the disease. At a severe stage, the renal transplantation option is adopted. Factors such as the high demand for treatment due to the increase in disease and various government policies to support the diagnosis are the factors driving the market growth. However, limited drug availability is restraining the market growth. Based on the treatment type, the therapy segment is going to have a lucrative growth during the forecast period due to the factors such as improved efficacy to treat symptoms, delayed renal transplantation, and novel therapeutic approaches being developed in recent times. The key vendors mentioned are AVROBIO, Inc, Chiesi Farmaceutici SpA, Eloxx Pharmaceuticals, GlaxoSmithKline plc, Horizon Therapeutics plc, Leadiant Biosciences, Inc, Mylan N.V, and Recordati Rare Diseases. Treatment Types Covered: • Renal Transplantation • Therapy Route of Administrations Covered: • Oral • Other Route of Administrations End Users Covered: • Ambulatory Surgical Centers • Clinics • Hospitals/Hospital Pharmacy Sales Channels Covered: • Specialty/Retail Pharmacies • Online Pharmacy Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2019 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analyzed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Nephropathic Cystinosis Treatment Market, By Treatment Type
5.1 Introduction
5.2 Renal Transplantation
5.3 Therapy
6 Global Nephropathic Cystinosis Treatment Market, By Route of Administration
6.1 Introduction
6.2 Oral
6.3 Other Route of Administrations
7 Global Nephropathic Cystinosis Treatment Market, By End User
7.1 Introduction
7.2 Ambulatory Surgical Centers
7.3 Clinics
7.4 Hospitals/Hospital Pharmacy
8 Global Nephropathic Cystinosis Treatment Market, By Sales Channel
8.1 Introduction
8.2 Specialty/Retail Pharmacies
8.3 Online Pharmacy
9 Global Nephropathic Cystinosis Treatment Market, By Geography
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 South America
9.6 Middle East & Africa
10 Strategic Benchmarking
11 Vendors Landscape
11.1 AVROBIO, Inc
11.2 Chiesi Farmaceutici SpA
11.3 Eloxx Pharmaceuticals
11.4 GlaxoSmithKline plc
11.5 Horizon Therapeutics plc
11.6 Leadiant Biosciences, Inc
11.7 Mylan N.V
11.8 Recordati Rare Diseases
List of Data Tables
1 Global Nephropathic Cystinosis Treatment Market Outlook, By Region (2018-2026) ($MN)
2 Global Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2026) ($MN)
3 Global Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2026) ($MN)
4 Global Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2026) ($MN)
5 Global Nephropathic Cystinosis Treatment Market Outlook, By Route of Administration (2018-2026) ($MN)
6 Global Nephropathic Cystinosis Treatment Market Outlook, By Oral (2018-2026) ($MN)
7 Global Nephropathic Cystinosis Treatment Market Outlook, By Other Route of Administrations (2018-2026) ($MN)
8 Global Nephropathic Cystinosis Treatment Market Outlook, By End User (2018-2026) ($MN)
9 Global Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centers (2018-2026) ($MN)
10 Global Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2026) ($MN)
11 Global Nephropathic Cystinosis Treatment Market Outlook, By Hospitals/Hospital Pharmacy (2018-2026) ($MN)
12 Global Nephropathic Cystinosis Treatment Market Outlook, By Sales Channel (2018-2026) ($MN)
13 Global Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2026) ($MN)
14 Global Nephropathic Cystinosis Treatment Market Outlook, By Online Pharmacy (2018-2026) ($MN)
15 North America Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2026) ($MN)
16 North America Nephropathic Cystinosis Treatment Market Outlook, By Route of Administration (2018-2026) ($MN)
17 North America Nephropathic Cystinosis Treatment Market Outlook, By End User (2018-2026) ($MN)
18 North America Nephropathic Cystinosis Treatment Market Outlook, By Sales Channel (2018-2026) ($MN)
19 Europe Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2026) ($MN)
20 Europe Nephropathic Cystinosis Treatment Market Outlook, By Route of Administration (2018-2026) ($MN)
21 Europe Nephropathic Cystinosis Treatment Market Outlook, By End User (2018-2026) ($MN)
22 Europe Nephropathic Cystinosis Treatment Market Outlook, By Sales Channel (2018-2026) ($MN)
23 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2026) ($MN)
24 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Route of Administration (2018-2026) ($MN)
25 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By End User (2018-2026) ($MN)
26 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Sales Channel (2018-2026) ($MN)
27 South America Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2026) ($MN)
28 South America Nephropathic Cystinosis Treatment Market Outlook, By Route of Administration (2018-2026) ($MN)
29 South America Nephropathic Cystinosis Treatment Market Outlook, By End User (2018-2026) ($MN)
30 South America Nephropathic Cystinosis Treatment Market Outlook, By Sales Channel (2018-2026) ($MN)
31 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2026) ($MN)
32 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Route of Administration (2018-2026) ($MN)
33 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By End User (2018-2026) ($MN)
34 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Sales Channel (2018-2026) ($MN)